These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2506954)

  • 1. Management of ITP with immunoglobulin anti-Rh0 (D).
    Colomina P; Cervero A; García S
    Blut; 1989 Sep; 59(3):240. PubMed ID: 2506954
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).
    Salama A; Kiefel V; Amberg R; Mueller-Eckhardt C
    Blut; 1984 Jul; 49(1):29-35. PubMed ID: 6430368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura.
    Oksenhendler E; Bierling P; Brossard Y; Schenmetzler C; Girard PM; Seligmann M; Clauvel JP
    Blood; 1988 May; 71(5):1499-502. PubMed ID: 2833961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhesus antibody treatment for idiopathic thrombocytopenic purpura in an Rh-negative patient.
    Rossi E; Damasio EE; Cerri R; Sogno G; Lercari G; Incagliato M; Marmont A
    Haematologica; 1988; 73(6):521-3. PubMed ID: 3148517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of immune thrombopenia].
    Egli F
    Schweiz Med Wochenschr; 1991 Jun; 121(23):851-7. PubMed ID: 1713347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous immunoglobulin in immune thrombocytopenia.
    Salama A; Mueller-Eckhardt C; Kiefel V
    Lancet; 1983 Jul; 2(8343):193-5. PubMed ID: 6135031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.
    Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF
    Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950
    [No Abstract]   [Full Text] [Related]  

  • 9. The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin.
    Smith NA; Chakraverty RK; Boughton BJ
    Clin Lab Haematol; 1990; 12(2):131-6. PubMed ID: 2119931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.
    Fehr J; Hofmann V; Kappeler U
    N Engl J Med; 1982 May; 306(21):1254-8. PubMed ID: 6803159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rhesus antibodies (Anti-Rh0 (D)) in autoimmune thrombocytopenia: correlation with response to high dose IgG and the degree of haemolysis.
    Panzer S; Grümayer ER; Haas OA; Niessner H; Graninger W
    Blut; 1986 Feb; 52(2):117-21. PubMed ID: 3081067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immunoglobulins in neonatal Rhesus haemolytic disease.
    Greenough A
    BioDrugs; 2001; 15(8):533-41. PubMed ID: 11543694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-rhesus antibodies, immune thrombocytopenia, and human immunodeficiency virus treatment.
    Bierling P; Karianakis G; Duedari N; Desaint C; Oksenhendler E; Habibi B; Brossard Y
    Ann Intern Med; 1987 May; 106(5):773-4. PubMed ID: 3105378
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding characteristics of anti-Rh0(D) antibodies to Rh0(D)-positive and Du red cells.
    Cunningham NA; Zola AP; Hui HL; Taylor LM; Green FA
    Blood; 1985 Oct; 66(4):765-8. PubMed ID: 3929857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Rh0(D) sensitization: a cost-effective analysis.
    Lim OW; Fleisher AA; Ziel HK
    Obstet Gynecol; 1982 Apr; 59(4):477-80. PubMed ID: 6176925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of anti-D in chronic idiopathic thrombocytopenic purpura.
    Yaprak I; Cağlayan S; Kansoy S; Ozdoğru E; Bakiler AR; Aydinlioğlu H
    Turk J Pediatr; 1994; 36(1):43-7. PubMed ID: 8191607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term response in a patient with ITP following low dose anti-D immunoglobulin therapy.
    Smith NA; Chakraverty RK; Obeid D; Boughton BJ
    Autoimmunity; 1989; 4(1-2):115-7. PubMed ID: 2562380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Rh(D) immunoglobulin for immune thrombocytopenic purpura.
    Contreras M; Mollison PL
    Lancet; 1986 Jul; 2(8497):49-50. PubMed ID: 2425201
    [No Abstract]   [Full Text] [Related]  

  • 20. Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
    Stasi R
    Curr Opin Mol Ther; 2010 Dec; 12(6):734-40. PubMed ID: 21154165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.